Moreover, the diagnostic model had a higher positive rate for BC detection than traditional circulating biomarkers (CEA, CA125, CA15-3, and CA19-9), suggesting that these results might describe a novel liquid biopsy method for diagnosing BC. The gene discussed is CEACAM5; the disease is breast cancer.